Newsfeeds - Spark Newswire

1 minute read

Provention Bio Q2 EPS $(0.46) Does Not Compare To $0.55 Estimate

Today, 6:25 AM

Provention Bio (NASDAQ:PRVB) reported quarterly losses of $(0.46) per share which missed the analyst consensus estimate of $0.55 by 183.64 percent. This is a 2.22 percent decrease over losses of $(0.45) per share from

PRVB

34 minute read

Earnings Scheduled For August 5, 2021

By Benzinga Insights

Today, 6:25 AM

Companies Reporting Before The Bell • OneSpaWorld Holdings (NASDAQ:OSW) is projected to report quarterly loss at $0.20 per share on revenue of $6.42 million.

AAOI

4 minute read

Attention Biotech Investors: Mark Your Calendar For August PDUFA Dates

By Shanthi Rexaline

Today, 6:25 AM

The month of July was disappointing from the perspective of Food and Drug Administration decisions, as the agency handed down mostly negative verdicts.

ALBO

6 minute read

The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs

By Shanthi Rexaline

Today, 6:25 AM

Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies.

ABUS

1 minute read

Provention Bio’s Teplizumab Awarded Innovation Passport In UK For Delay Of Onset Of Clinical Type 1 Diabetes In At-Risk Individuals

By Bill Haddad

Today, 6:25 AM

Provention Bio, Inc. (NASDAQ:PRVB), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, today announced that teplizumab, an anti-CD3 monoclonal antibody (mAb), was awarded an

PRVB

3 minute read

The Week Ahead In Biotech: Adcom Test Awaits FibroGen, Data Readouts, IPOs In The Mix

By Shanthi Rexaline

Today, 6:25 AM

Biopharma stocks closed the holiday-shortened week lower amid a lack of any significant news flow.

ALEC

5 minute read

The Daily Biotech Pulse: Priority Review For Amgen’s Asthma Treatment, Evaxion Reports Positive Skin Cancer Readout, Quidel Recalls Lyra COVID-19 Test

By Shanthi Rexaline

Today, 6:25 AM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 7)

ABCL

5 minute read

The Daily Biotech Pulse: Opiant Spikes On Data, OncoSec Rallies On Merck Collaboration, XBiotech Special Dividend

By Shanthi Rexaline

Today, 6:25 AM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 6)

ABCL

5 minute read

61 Biggest Movers From Yesterday

By Lisa Levin

Today, 6:25 AM

Gainers BSQUARE Corporation (NASDAQ: BSQR) shares climbed 77.1% to close at $7.05 on Tuesday on abnormally-high volume. The company’s stock dropped around 10% on Friday.

ADXS

3 minute read

Mid-Afternoon Market Update: Dow Tumbles 300 Points; Advaxis Shares Spike Higher

By Lisa Levin

Today, 6:25 AM

Toward the end of trading Tuesday, the Dow traded down 0.86% to 34,488.53 while the NASDAQ fell 0.08% to 14,626.98. The S&P also fell, dropping 0.48% to 4,331.47.

ADXS